Advertisement

Topics

Orphan-drug grant will support immune thrombocytopenia treatment

05:23 EDT 22 Aug 2017 | SmartBrief

The FDA Office of Orphan Products Development awarded Protalex a $403,000 grant to further clinical development of a treatmen -More

Original Article: Orphan-drug grant will support immune thrombocytopenia treatment

NEXT ARTICLE

More From BioPortfolio on "Orphan-drug grant will support immune thrombocytopenia treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...